Published on
December 6, 2023
- 19:24 GMT
Human medicines European public assessment report (EPAR): Inovelon, rufinamide, Date of authorisation: 16/01/2007, Revision: 24, ...
In a main study involving 139 patients aged between 4 and 30 years (three quarters of them below 17 years old) Inovelon caused a reduction in the number and severity of seizures. All of the patients had Lennox-Gastaut syndrome that was not controlled …
Distribution channels:
Healthcare & Pharmaceuticals Industry
